nach oben

Journal of Neuro-Oncology

Erschienen in:

31.10.2021 | Laboratory Investigation

Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy

verfasst von: Tokunori Kanazawa, Kentaro Ohara, Yohei Kitamura, Masato Nakaya, Kazunari Yoshida, Hikaru Sasaki

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Lower grade gliomas with 1p/19q codeletion are often responsive to chemotherapy, and several of these have been treated using upfront chemotherapy and subsequent resection following tumor volume decrease. This study aimed to elucidate the histological changes and the mechanism of recurrence after alkylating agent chemotherapy in 1p/19-codeleted gliomas.

Methods

Fourteen 1p/19q-codeleted gliomas resected following tumor volume decrease after alkylating agent chemotherapy were included and compared with their pre-chemotherapy specimens. Histological changes were investigated using hematoxylin–eosin staining, and changes in proliferative activity, status of glioma stem cells (GSCs), and tumor-infiltrating macrophages were assessed using immunohistochemistry for Ki-67/MIB-1, CD68 as a pan-macrophage/monocyte marker, CD163 as a presumed marker of M2 polarity, and nestin and CD133 as markers of GSCs.

Results

The most frequent histological findings following chemotherapy included a sparse glial background and abundant foamy cell infiltration. The Ki-67/MIB-1 index decreased and the number of CD68 + cells increased after chemotherapy. The increasing rate of CD68 + cells in the post-/pre-chemotherapy specimens was inversely correlated with patient prognosis but not tumor response. The number of CD163 + cells, M2/M1 + M2 ratio, and the ratio of GSCs to total tumor cells increased after chemotherapy, and those in the post-chemotherapy specimens were negatively correlated with patient prognosis. There was a correlation between the M2/M1 + M2 ratio and the ratio of GSCs in both pre- and post-chemotherapy specimens.

Conclusion

GSCs in conjunction with M2 macrophages constitute the mechanism of resistance to and recurrence after alkylating agent chemotherapy in 1p/19q-codeleted gliomas.

Nur mit Berechtigung zugänglich

Darnton SJ, Allen SM, Edwards CW, Matthews HR (1993) Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. J Clin Pathol 46(1):51–55CrossRefPubMedPubMedCentral

Langer R, Ott K, Feith M, Lordick F, Siewert JR, Becker K (2009) Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas. Mod Pathol 22(12):1555–1563CrossRefPubMed

Kurosumi M, Akashi-Tanaka S, Akiyama F et al (2008) Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer 15(1):5–7CrossRefPubMed

Schiffer D, Giordana MT, Buoncristiani P, Paoletti P (1978) Human malignant gliomas treated with chemotherapy: a pathological study. Neurosurgery 3(3):344–347CrossRefPubMed

Schiffer D, Giordana MT, Paoletti P, Soffietti R, Tarenzi L (1980) Pathology of human malignant gliomas after radiation and chemotherapy. Acta Neurochir 53(3–4):205–216CrossRefPubMed

Fischer I, Cunliffe CH, Bollo RJ et al (2008) High-grade glioma before and after treatment with radiation and Avastin: initial observations. Neuro Oncol 10(5):700–708CrossRefPubMedPubMedCentral

DeLay M, Jahangiri A, Carbonell WS et al (2012) Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy. Clin Cancer Res 18(10):2930–2942CrossRefPubMedPubMedCentral

Woo JY, Yang SH, Lee YS, Lee SY, Kim J, Hong YK (2015) Continuous low-dose temozolomide chemotherapy and microvessel density in recurrent glioblastoma. J Korean Neurosurg Soc 58(5):426–431CrossRefPubMedPubMedCentral

Tamura R, Tanaka T, Miyake K et al (2016) Histopathological investigation of glioblastomas resected under bevacizumab treatment. Oncotarget 7(32):52423–52435CrossRefPubMedPubMedCentral

10.

Sasaki H, Hirose Y, Yazaki T et al (2015) Upfront chemotherapy and subsequent resection for molecularly defined gliomas. J Neurooncol 124(1):127–135CrossRefPubMed

11.

Louis DN, Ohgaki H, Wiestler OD, et al. (2016) WHO classification of tumours of the central nervous system. Revised 4th edn. Lyon: International Agency for Research on Cancer

12.

Kitamura Y, Sasaki H, Kimura T et al (2013) Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis. J Neuropathol Exp Neurol 72(9):816–823CrossRefPubMed

13.

Cui L, Rashdan NA, Zhu D et al (2017) End stage renal disease-induced hypercalcemia may promote aortic valve calcification via annexin VI enrichment of valve interstitial cell derived-matrix vesicles. J Cell Physiol 232(11):2985–2995CrossRefPubMedPubMedCentral

14.

Strojnik T, Røsland GV, Sakariassen PO, Kavalar R, Lah T (2007) Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 68(2):133–143CrossRefPubMed

15.

Zhang M, Song T, Yang L et al (2008) Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27(1):85CrossRefPubMedPubMedCentral

16.

van den Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12(6):583–593CrossRefPubMed

17.

Blumenthal DT, Aisenstein O, Ben-Horin I et al (2015) Calcification in high grade gliomas treated with bevacizumab. J Neuro-Oncol 123(2):283–288CrossRef

18.

Sethi D, Sen R, Parshad S, Khetarpal S, Garg M, Sen J (2012) Histopathologic changes following neoadjuvant chemotherapy in various malignancies. Int J Appl Basic Med Res 2(2):111–116CrossRefPubMedPubMedCentral

19.

Liu G, Yuan X, Zeng Z et al (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67CrossRefPubMedPubMedCentral

20.

Fillmore CM, Kuperwasser C (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10(2):R25CrossRefPubMedPubMedCentral

21.

Tanei T, Morimoto K, Shimazu K et al (2009) Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 15(12):4234–4241CrossRefPubMed

22.

Aomatsu N, Yashiro M, Kashiwagi S et al (2012) CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer. PLoS ONE 7(9):e45865CrossRefPubMedPubMedCentral

23.

Dell’Albani P (2008) Stem cell markers in gliomas. Neurochem Res 33(12):2407–2415CrossRefPubMed

24.

Dahlrot RH, Hermansen SK, Hansen S, Kristensen BW (2013) What is the clinical value of cancer stem cell markers in gliomas? Int J Clin Exp Pathol 6(3):334–348PubMedCentralPubMed

25.

Wu B, Sun C, Feng F, Ge M, Xia L (2015) Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis. J Exp Clin Cancer Res 34(1):44CrossRefPubMedPubMedCentral

26.

Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6:13

27.

Tamura R, Tanaka T, Yamamoto Y, Akasaki Y, Sasaki H (2018) Dual role of macrophage in tumor immunity. Immunotherapy 10(10):899–909CrossRefPubMed

28.

Zeiner PS, Preusse C, Golebiewska A et al (2019) Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas. Brain Pathol 29(4):513–529CrossRefPubMedPubMedCentral

29.

Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR, Yang SM (2012) Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012:948098CrossRefPubMedPubMedCentral

30.

Chanmee T, Ontong P, Konno K, Itano N (2014) Tumor-associated macrophages as major players in the tumor microenvironment. Cancers 6(3):1670–1690CrossRefPubMedPubMedCentral

31.

Zhou W, Ke SQ, Huang Z et al (2015) Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol 17(2):170–182CrossRefPubMedPubMedCentral

Titel: Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy
verfasst von: Tokunori Kanazawa
Kentaro Ohara
Yohei Kitamura
Masato Nakaya
Kazunari Yoshida
Hikaru Sasaki
Publikationsdatum: 31.10.2021
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2021
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-021-03855-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Surgical strategies for older patients with glioblastoma

Mitochondrial DNA sequence variation and risk of meningioma

The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery

Increased proliferation is associated with CNS invasion in meningiomas

Combining 18F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study